BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 34407784)

  • 1. Clinical analysis of second-trimester pregnancy termination after previous caesarean delivery in 51 patients with placenta previa and placenta accreta spectrum: a retrospective study.
    Hu Q; Li C; Luo L; Li J; Zhang X; Chen S; Yang X
    BMC Pregnancy Childbirth; 2021 Aug; 21(1):568. PubMed ID: 34407784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study.
    Cui R; Li M; Lu J; Bai H; Zhang Z
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):298. PubMed ID: 29996794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors of pregnancy termination at second and third trimester in women with scarred uterus and placenta previa].
    Tian JS; Pan FX; He SN; Hu WS
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 May; 44(3):247-52. PubMed ID: 26350003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical analysis of prophylactic uterine artery embolization combined with double balloon catheter for second-trimester pregnancy termination in cases of complete placenta previa: A retrospective study.
    Li H; Cheng W; Wen J; Peng J; Wu S; Zhao Y; Xia W
    Medicine (Baltimore); 2023 Nov; 102(47):e36240. PubMed ID: 38013334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prophylactic uterine artery embolization on second-trimester induced abortions in patients with placenta previa.
    Wang N; Li XM; Fei YL; Liu YM; Lin J; Jiang XX
    Int J Gynaecol Obstet; 2018 Nov; 143(2):205-210. PubMed ID: 30076600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine artery embolization, not cesarean section, as an option for termination of pregnancy in placenta previa.
    Huang L; Awale R; Tang H; Zeng Z; Li F; Chen Y
    Taiwan J Obstet Gynecol; 2015 Apr; 54(2):191-3. PubMed ID: 25951727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone combined with ethacridine lactate for the second-trimester pregnancy termination in women with placenta previa and/or prior cesarean deliveries.
    Chen C; Lin F; Wang X; Jiang Y; Wu S
    Arch Gynecol Obstet; 2017 Jan; 295(1):119-124. PubMed ID: 27658386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of patients with placenta accreta spectrum disorders who underwent pregnancy terminations in the second trimester: A retrospective study.
    Ou J; Peng P; Teng L; Li C; Liu X
    Eur J Obstet Gynecol Reprod Biol; 2019 Nov; 242():109-113. PubMed ID: 31580962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induced termination of second and third trimester pregnancy in women with scarred uterus].
    Zou LY; Fan L
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):17-21. PubMed ID: 20367920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 12. The method for termination of mid-trimester pregnancy with placenta previa: A case study.
    Long Q; Wu S; Du S; Li R; Zhao Y; Tang F
    Medicine (Baltimore); 2022 Aug; 101(31):e29908. PubMed ID: 35945718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal outcome after conservative management of abnormally invasive placenta.
    Su HW; Yi YC; Tseng JJ; Chen WC; Chen YF; Kung HF; Chou MM
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):353-357. PubMed ID: 28600047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique.
    Palacios-Jaraquemada JM; Fiorillo A; Hamer J; Martínez M; Bruno C
    J Matern Fetal Neonatal Med; 2022 Jan; 35(2):275-282. PubMed ID: 31984808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center.
    Varlas VN; Bors RG; Birsanu S; Maxim B; Clotea E; Mihailov M
    J Med Life; 2021; 14(3):367-375. PubMed ID: 34377203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of prophylactic balloon occlusion of the internal iliac artery for the treatment of placenta accreta spectrum with placenta previa: a retrospective case-control study.
    Peng Y; Jiang L; Peng C; Wu D; Chen L
    BMC Pregnancy Childbirth; 2020 Jun; 20(1):349. PubMed ID: 32513127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery.
    Coutinho CM; Giorgione V; Noel L; Liu B; Chandraharan E; Pryce J; Frick AP; Thilaganathan B; Bhide A
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):91-96. PubMed ID: 32865834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative aortic balloon occlusion in patients with placenta previa and/or placenta accreta: a retrospective study.
    Luo F; Xie L; Xie P; Liu S; Zhu Y
    Taiwan J Obstet Gynecol; 2017 Apr; 56(2):147-152. PubMed ID: 28420498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outcome analysis of pregnancy termination and expectant treatment in pregnant women with suspected invasive placenta accreta spectrum disorders in the second trimester].
    Chen L; Wang Y; Liang SY; Shi HF; Zhao YY
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jul; 58(7):489-494. PubMed ID: 37474321
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for massive bleeding based on angiographic findings in patients with placenta previa and accreta who underwent balloon occlusion of the internal iliac artery during cesarean section.
    Tokue H; Tokue A; Tsushima Y; Kameda T
    Br J Radiol; 2019 Oct; 92(1102):20190127. PubMed ID: 31317769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.